Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD

INTRODUCTION: Vaccination against the coronavirus disease 2019 (COVID-19) is recommended for patients with multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). However, vaccine safety in these patients t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sohyeon, Seok, Hung Youl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924883/
https://www.ncbi.nlm.nih.gov/pubmed/36781562
http://dx.doi.org/10.1007/s10072-023-06676-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924883/
https://www.ncbi.nlm.nih.gov/pubmed/36781562
http://dx.doi.org/10.1007/s10072-023-06676-1

Ejemplares similares